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ColonizationwithamixtureofClostridiumspecieshas
been shown to induce accumulation of induced regu-
latory T (iTreg) cells in the colon. Transforming growth
factor-b (TGF-b) is an essential factor for iTreg cell
induction; however, the relationship between Clos-
tridium species and TGF-b remains to be clarified.
Here we demonstrated that a gram-positive probiotic
bacterial strain,Clostridiumbutyricum (C. butyricum),
promoted iTreg cell generation in the intestine
through induction of TGF-b1 from lamina propria
dendritic cells (LPDCs). C. butyricum-mediated TGF-
b1 induction was mainly Toll-like receptor 2 (TLR2)
dependent, and the ERK-AP-1 kinase pathway
played an important role. In addition, the autocrine
TGF-b-Smad3 transcription factor signal was neces-
sary for robust TGF-b expression in DCs, whereas
Smad2 negatively regulated TGF-b expression.
Smad2-deficient DCs expressed higher concentra-
tionsofTGF-bandwere tolerogenic for colitismodels.
This study reveals anovelmechanismofTGF-b induc-
tion by Clostridia through a cooperation between
TLR2-AP-1 and TGF-b-Smad signaling pathways.
INTRODUCTION
Intestinal microbiota contribute to many host physiological pro-
cesses, including nutrient acquisition and development of the
gut-specific immune system, as well as protection from infec-
tious pathogens (Hill and Artis, 2010; Hooper et al., 2012).
Recent advances in the field of mucosal immunology have
uncovered several roles of intestinal microbiota in the establish-
ment of interleukin-17 (IL-17)-producing helper T (Th17) cells andregulatory T (Treg) cells (Ivanov and Honda, 2012). A complex
mixture of 46 strains of Clostridium has been shown to promote
the subsequent accumulation of IL-10-producing iTreg cells in
mice, which suppresses colitis in a dextran sodium sulfate
(DSS) colitis model (Atarashi et al., 2011). The same group also
identified the 17 strains of clusters IV, XIVa, and XVIII ofClostridia
from the human indigenous microbiota that provide bacterial
antigens and a transforming growth factor b (TGF-b)-rich envi-
ronment to help expansion and differentiation of iTreg cells (Atar-
ashi et al., 2013).
The molecular mechanism of iTreg cell induction by Clostridia
remains to be clarified. At present, it has been well established
that TGF-b and its downstream transcription factors Smad2
and Smad3 are essential for iTreg cell generation (Chen et al.,
2003; Takimoto et al., 2010). Atarashi et al. (2011, 2013) has
shown that Clostridium species induce TGF-b from epithelial
cells. On the other hand, several groups have shown that micro-
bial metabolites such as a short-chain fatty acid, butyrate, facil-
itate iTreg cell generation (Arpaia et al., 2013; Furusawa et al.,
2013). Butyrate could inhibit histone deacetylase (HDAC), result-
ing in enhanced histone H3 acetylation in the promoter and
conserved non-coding sequence (CNS) regions of the Foxp3
locus. However, butyrate alone does not induce iTreg cells,
and TGF-b is still essential for iTreg cell development even in
the presence of butyrate.
Although TGF-b is produced by a large variety of cells in the
intestinal mucosa, including intestinal epithelial cells, lympho-
cytes, macrophages, and dendritic cells (DCs), the source of
TGF-b for iTreg cell generation in the intestine has not been
determined. Several reports indicate that a population of
CD103+ DCs in mesenteric lymph nodes (mLNs) is important
for the development of iTreg cells in a retinoic acid (RA)-depen-
dent manner (Coombes and Powrie, 2008). Another report
shows that LPDCs in the small intestine possess a higher poten-
tial to generate iTreg cells than lymphoid organ-derived DCs
(Sun et al., 2007). Although it is not clear where iTreg cells are
developed, CD103+ DCs in the intestine are now widely believedImmunity 43, 65–79, July 21, 2015 ª2015 Elsevier Inc. 65
to induce iTreg cells by providing antigens, RA, and TGF-b (Ben-
son et al., 2007; Coombes et al., 2007; Ruane and Lavelle, 2011).
In addition, TGF-b signals inside DCs are also necessary for
proper Foxp3+ T cell development: DC-specific disruption of
TGF-b receptor II shows abnormal Treg cell phenotypes (Rama-
lingam et al., 2012). However, the function of the TGF-b signal in
DCs for Treg cell development has not been clarified.
Clostridium butyricum (C. butyricum) is classified in Clos-
tridium cluster I and is a groupmember of allochthonous bacteria
(Sato and Tanaka, 1997). C. butyricum has been used as a pro-
biotic in clinical practice (Seki et al., 2003), and we have demon-
strated that administration of the probiotic bacterial strain
C. butyricum prevents experimental colitis (Hayashi et al.,
2013). We have shown that depletion of Treg cells by anti-
CD25 Ab overrides the protective effect of C. butyricum, raising
a possibility that C. butyricum affects Treg cell development
(Hayashi et al., 2013).
In the present study, we demonstrate that C. butyricum
promoted iTreg cell generation by inducing large amounts of
TGF-b from DCs both in vivo and in vitro. Induction of TGF-b
was toll-like receptor-2 (TLR2) dependent, and the ERK-AP-1
kinase pathway played an important role for TGF-b promoter
activation. We also identified an autoinduction mechanism of
TGF-b production in which Smad3 directly activated the Tgfb1
promoter. Smad2 had an opposite function that inhibited the
Tgfb1 promoter activation. Consistent with this observation,
Smad2-deficient bone-marrow-derived DCs (BMDCs) induced
more iTreg cells than wild-type (WT) BMDCs, and adoptive
transfer of Smad2/ DCs ameliorated experimental colitis.
This study revealed the importance of the autoinduction mech-
anism of TGF-b for efficient iTreg cell generation and immune
tolerance by DCs.
RESULTS
C. butyricum Suppresses Experimental Colitis by a
TGF-b-Dependent Mechanism
To investigate the relationship among C. butyricum, TGF-b, and
iTreg cells, we performed a DSS-induced acute colitis model
after treatment of mice with C. butyricum spore. Consistent
with the previous report (Hayashi et al., 2013), C. butyricum
administration reduced the severity of DSS-induced colitis as
judged from body weight loss and colon length (Figure 1A).
C. butyricum administration reduced the expression of inflam-
matory cytokines including interleukin-12 p40 (IL-12p40), tumor
necrosis factor-a (TNF-a), and IL-6, but increased IL-10 and
TGF-b1, in colonic lamina propria DCs (LPDCs) on day 8 after
DSS treatment (Figure 1B). Because Tgfb2 and Tgfb3 mRNA
amounts were much lower (<2%) than Tgfb1 (Figure 1B), we
used TGF-b as TGF-b1 hereafter unless otherwise noted.
To confirm the protective role of TGF-b in the DSS-induced
colitis model, we treated mice with anti-TGF-b antibody (Ab).
Anti-TGF-b Ab abrogated the protective effect of C. butyricum
on colitis (Figure 1A) and the suppressive effect on the inflamma-
tory cytokine expression in LPDCs (Figure 1B). Anti-TGF-b Ab
had little effect on IL-10, whereas Tgfb1 expression in DCs
was reduced by anti-TGF-b Ab treatment (Figure 1B). Interfer-
fon-g (IFN-g) expression in CD4+ T cells was enhanced by DSS
treatment, which was reduced by C. butyricum administration.66 Immunity 43, 65–79, July 21, 2015 ª2015 Elsevier Inc.This protective effect of C. butyricum was also reverted by
anti-TGF-b-Ab (Figure S1A). C. butyricum exhibited a reduced
T helper 1 (Th1) cell induction potential compared with E. coli
or Enterococcus faecalis in mixed lymphocyte reaction (MLR)
in vitro (Figures S1B and S1C). These data suggest that the
anti-inflammatory effect of C. butyricum against DSS-induced
colitis is associated with TGF-b-dependent reduction of IFN-g
expression.
We then examined the effect of C. butyricum and TGF-b on
iTreg cell development. As reported previously (Atarashi et al.,
2011), approximately 60%–70% of Foxp3+CD4+ Treg cells in
the colonwere Helios negative, i.e., they were iTreg cells (Figures
1C and 1E). After C. butyricum administration for 2 weeks, the
fraction of Foxp3+ cells among CD4+ T cells increased 2-fold
(Figures 1C and 1D), whichwasmostly due to the increase of He-
lios iTreg cells (Figures 1C and 1E). Anti-TGF-b Ab abrogated
the effect of C. butyricum on the increase of iTreg cells (Figures
1C and 1D) and partly reduced Helios iTreg cells (Figure 1E).
These data indicate that C. butyricum promotes the develop-
ment of iTreg cells in the colon by enhancing TGF-b expression.
To determine which cells (epithelial cells or DCs) are important
source of TGF-b for iTreg cell induction, we compared Tgfb1
mRNA contents in EpCAM+ epithelial cells and CD11c+ LPDCs.
As shown in Figure 1F, Tgfb1mRNA amounts per cell weremuch
higher in LPDCs than in epithelial cells in vivo. In addition, the
response to C. butyricum was also greater in LPDCs than in
epithelial cells (Figure 1F). Depletion of DCs by using Itgax-
DTR mice (Ohnmacht et al., 2009) resulted in the reduction of
TGF-b and Foxp3 expression in the whole intestine (Figures
S1D and S1E). To clarify which cells in the LPDC fraction pro-
duce TGF-b, we separated CD11c+MHC-IIhi cells by CD103
and CX3CR1 expression (Varol et al., 2009). CD103
+CX3CR1

DCs expressed the highest amount of TGF-b in response to
C. butyricum administration in vivo (Figure S1F). These data
are consistent with previous reports indicating that CD103+
DCs are most important for iTreg cell induction (Coombes
et al., 2007; Sun et al., 2007; Worthington et al., 2011).
TLR Signals Promote TGF-b Production in DCs
Wenoticed that the protective effect against DSS-induced colitis
was observed even when heat-killed C. butyricum was adminis-
tered (Figure S2), suggesting that components of C. butyricum
were probably sufficient to induce TGF-b. Therefore, we first
measured TGF-b expression in vitro from isolated LPDCs in
response to major TLR ligands (Figure 2A). Epithelial cells were
used as a control. Similar toC. butyricum, both LPS (lipopolysac-
charide, a TLR4 ligand) and PGN (peptidoglycan, a TLR2 ligand)
induced Tgfb1 expression in primary LPDCs; however, PGN
showed a stronger effect than LPS (Figure 2A). Although epithe-
lial cells responded to PGN, the responsewasmuchweaker than
that of LPDCs (Figure 2A).
Next, we asked whether BMDCs exhibit a TGF-b production
similar to LPDCs in response to bacteria and TLR ligands.
TGF-b protein concentration was measured with a reporter cell
line, MFB-F11, by which both total and biologically active forms
of TGF-b can be detected with extremely high sensitivity (Matsu-
mura et al., 2007). As shown in Figure 2B, BMDCs secreted
TGF-b at high concentrations in response to heat-killed bacteria
(C. butyricum and E. coli) and TLR ligands (LPS and PGN),
Figure 1. Clostridium butyricum Promotes TGF-b-Dependent iTreg Cell Development in the Lamina Propria and Suppresses Acute
DSS-Induced Colitis
(A) Body weight changes of mice administered with C. butyricum (CB) with or without anti-TGF-b Ab (Ab) during DSS-induced colitis. Colon length on day 8 was
alsomeasured (right). C57BL/6mice were fedwith a normal diet () or a diet containingC. butyricum for 2 weeks. Neutralizing anti-TGF-bAbwas intraperitoneally
injected on days 14, 7, and 0 of DSS treatment.
(B) Quantitative RT-PCR (qRT-PCR) analysis of cytokinemRNA amounts in CD11c+ DCs isolated from colonic LPDCs on day 8 after DSS treatment. Expression is
normalized to Hprt. Each circle represents an individual animal.
(C–E) Mice were administered C. butyricum with or without anti-TGF-b Ab for 2 weeks. LP mononuclear cells were isolated from colonic LP and stained with
anti-CD4, anti-Foxp3, and anti-Helios antibodies. The percentage of Foxp3+ within the CD4+ cells (D) and the percentage of Helios cells within the Foxp3+ cells
(E) in the colonic LP of the indicated mice are shown.
(F) Comparison of Tgfb1 mRNA amounts in CD45EpCAM+ intestinal epithelial cells (IECs) and CD11c+ LPDCs in mice fed with or without C. butyricum. FACS
profiles of IECs are shown in the right panel. Tgfb1 mRNA content was measured by qRT-PCR.
All data represent the mean ± SEM (nR 5 mice group). *p < 0.05, **p < 0.01. Data were pooled from two independent experiments. See also Figure S1.
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Figure 2. TLR2-Dependent TGF-b Production from DCs
(A) Tgfb1 mRNA expression in CD45EpCAM+ IELs and CD11c+ LPDCs form normal-diet mice stimulated with or without 100 ng/ml LPS or 100 ng/ml PGN for
3 hr. Relative Tgfb1 mRNA contents (fold increase) are shown compared with those without stimulation.
(B) TGF-b amounts from CMT-93 cells and BMDCs (1 3 106) stimulated with the indicated materials for 24 hr. Total TGF-b concentrations in the culture
supernatant were measured by the SEAP assay.
(legend continued on next page)
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compared with the colonic epithelial cell line CMT-93. Heat-
killed C. butyricum also induced TGF-b production from BMDCs
more strongly than did E. coli (Figure 2B). Short chain fatty acids,
which have been shown to facilitate Foxp3 transcription factor
expression in iTreg cells, had little effect on TGF-b production.
Similar to LPDCs, Tgfb2 and Tgfb3 expression was much lower
compared to Tgfb1 in stimulated BMDCs (data not shown). LPS
and PGN dose dependently induced both total and bioactive
TGF-b expression in BMDCs. Like LPDCs (Figure 2A), PGN
induced higher amount of TGF-b compared with LPS in BMDCs
(Figure 2C). Although only a small fraction was converted to the
bioactive form by BMDCs, PGN was always two to three times
more effective than LPS on bioactive TGF-b expression (Fig-
ure 2C). These data suggest that TLR2 ligand stimulates TGF-b
production more preferentially compared with the TLR4 ligand
both in LPDCs and BMDCs.
To confirm that C. butyricum induced TGF-b mainly through
TLR2 in vivo, we compared Tgfb expression in LPDCs
from Tlr2/, Tlr4/, and Tlr2/Ttlr4/ mice treated with
C. butyricum. As shown in Figure 2D, Tgfb1 expression in LPDCs
in vivo depended strongly on TLR2 and weakly on TLR4. Again,
Tgfb2 and Tgfb3 were much lower than Tgfb1. Induction of
TGF-b by C. butyricum was severely impaired in Tlr2/Tlr4/
mice (Figure 2D). Similarly, TGF-b production from BMDCs
stimulated with C. butyricum in vitro was almost completely
abolished by both TLR2 and TLR4 deficiency; however, TLR2
deficiency showed more profound effect than TLR4 (Figure 2E).
These data indicated that C. butyricum utilized both TLR2 and
TLR4 to induce TGF-b, but the contribution of TLR2 was much
greater than that of TLR4.
To demonstrate that TLR2-mediated TGF-b from DCs is
important for iTreg cell generation, naive CD4+ T cells from
BALB/c mice were co-cultured with LPS- or PGN-primed
BMDCs fromC57BL/6 mice (Figures 2F and 2G). PGN enhanced
the ability of BMDCs to induce Foxp3+ iTreg cells more potently
than did LPS. Anti-TGF-b Ab completely abolished the induction
of iTreg cells by BMDCs. These data indicate that TLR2 signal-
mediated TGF-b production in DCs plays a role in iTreg cell
induction.
The ERK-AP-1 Pathway Promotes TGF-b
Expression in DCs
We screened chemical inhibitors to examine the mechanism
that induces TGF-b expression downstream of TLR2. Major
TLR signaling pathways are the IKK-NF-kB pathway, p38,
JNK and ERK MAP kinases, and the GSK3b-CREB pathway.
Among inhibitors of these pathways, the MEK inhibitor U0126
most strongly reduced the expression of TGF-b from PGN-
stimulated BMDCs (Figure 3A, MEKi). Because U0126 sup-(C) Dose response to LPS and PGN for total (left) and active (right) TGF-b producti
24 hr. Active TGF-b was measured without acid treatment. Data were pooled fro
(D) mRNA contents of TGF-b family genes in LPDCs isolated from Tlr2/, Tlr4/
(E) WT, Tlr2/, and Tlr4/ BMDCs were treated with respective stimulation for
assay.
(F and G) C57BL/6 BMDCs were primed with LPS or PGN for 24 hr, then co-cultur
or absence of anti-TGF-b Ab. Foxp3+ and CD4+ cells were analyzed by flow cytom
of the percentage of Foxp3+ cells among CD4+ T cells are shown in (G).
Data represent the mean ± SEM (n = 3). *p < 0.05, **p < 0.01. Data are represenpresses the ERK-AP-1 pathway and AP-1 has been shown to
be involved in TGF-b promoter activation (Birchenall-Roberts
et al., 1990), we focused on ERK and AP-1. Several reports
have suggested that the ERK-AP-1 pathway is differentially
activated by TLR2 and TLR4 (Agrawal et al., 2003; Re and Stro-
minger, 2001). Therefore, we examined the activation kinetics
of MAP kinases via immunoblotting. PGN more strongly
activated ERK and induced c-Fos than LPS did (Figure 3B).
c-Jun, a partner of c-Fos, was constitutively expressed regard-
less of the stimulation.
Next, we analyzed the Tgfb1 promoter to examine whether
AP-1 is directly involved in Tgfb1 induction. The non-coding
region of the Tgfb1 promoter upstream of exon 1 (265
to 1; putative CNS1) and a distal region (1783 to 1273; pu-
tative CNS2) were highly conserved among species (Figure 3C).
Tgfb1 promoter reporter constructs (Kinjyo et al., 2006) were
transfected into HEK293T cells expressing TLR2, then stimu-
lated with PGN. The reporter assay revealed that the CNS2
region contained PGN-responsive elements, where one AP-1
binding sequence (50-TGAGTCA-30; 1403 to 1397) exists
(Figure 3D). TLR2-mediated recruitment of AP-1 to this site
was confirmed by chromatin immunoprecipitation (ChIP) assay
with anti-c-Fos and anti-c-Jun antibodies (Figure 3E). Both
c-Fos and c-Jun proteins were recruited specifically to this
site after stimulation with PGN in BMDCs. Recruitment of
AP-1 to this site was much more intense by PGN stimulation
than by LPS stimulation (Figure 3E). Accordingly, transcription-
ally active histone modifications such as histone H3 and H4
acetylation (AcH3 and AcH4) and H3 lysine 4 trimethylation
(H3K4me3) were strongly enhanced by PGN in this AP-1
region, whereas repressive histone modification, such as
H3K27me3 and H3K9m3, were not affected (Figure 3E, AcH3
and Figure S3A). These data indicate that the TLR2-ERK signal
recruits AP-1 to CNS2 and induce active histone modifications
in the Tgfb1 promoter.
Next we used DC-specific Fos/ (FosDDC/DDC) mice (Figures
3F–3I). PGN-mediated TGF-b protein production was signifi-
cantly reduced in FosD/D BMDCs (Figure 3F), and active histone
modifications of the AP-1 binding region were not induced, while
repressive modifications were increased, in FosD/D BMDCs (Fig-
ures 3G and S3B). TGF-b mRNA expression was severely
reduced in LPDCs from FosDDC/DDC mice compared with WT
mice (Figure 3H). In the colon, iTreg and nTreg cells were distin-
guished by Neuropilin-1 (Nrp1) expression (Figure S3C; Yadav
et al., 2012). Consistently, Foxp3+ fraction in CD4+ T cells as
well as Nrp1 iTreg cell fraction were reduced in FosDDC/DDC
mice (Figure 3I). Our data suggest that AP-1 activated by the
TLR2-ERK pathway plays an essential role in both TGF-b induc-
tion in DCs and iTreg cell generation in vivo.on fromBMDCs stimulated with the indicated concentrations of LPS or PGN for
m three independent experiments.
, and Tlr2/Ttlr4/ mice treated with C. butyricum for 2 weeks (n = 3–5).
24 hr, and total TGF-b in the culture supernatant was measured by the SEAP
ed with CD4+CD62L+ naive T cells from BALB/c mice for 3 days in the presence
etry. Representative flow cytometry data are shown in (F) and quantitative data
tative of three independent experiments. See also Figure S2.
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Figure 3. AP-1 Plays an Important Role in TLR-Mediated TGF-b Expression
(A) BMDCs were cultured with the indicated inhibitors for 2 hr before and during treatment with 100 ng/ml PGN for 24 hr. TGF-b in the culture supernatant was
measured by SEAP assay.
(B) Immunoblotting of signaling molecules in BMDCs treated with LPS or PGN. BMDCs were stimulated with 10 ng/ml LPS or PGN for the indicated periods.
(legend continued on next page)
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Autoinduction of TGF-b Is Mediated by Smad3 and
Repressed by Smad2
Chemical inhibitor screening revealed that the TGF-b receptor I
kinase inhibitor (TGFbRIi) also strongly suppressed TGF-b pro-
duction from DCs (Figure 3A). Although autocrine induction
(autoinduction) of TGF-b is known in tumor cells (Kim et al.,
1990), the significance of this process in DCs has not been inves-
tigated. We confirmed that exogenous TGF-b induced TGF-b
mRNA transcription both in BMDCs and LPDCs (Figure S4A).
Because Smad2 and Smad3 are the major downstream tran-
scription factors of the TGF-b signaling, we examined the
involvement of these Smads in autoinduction of TGF-b by using
Smad2- and Smad3-deficient BMDCs. Smad2 was specifically
deleted in DCs by crossing Itgax-cre mice with Smad2flox/flox
(Smad2DDC/DDC) mice (Figures S4B and S4C).
As shown in Figures 4A and 4B, Smad3-deficient BMDCs
produced extremely low TGF-b protein and Tgfb1 mRNA in
response to PGN or C. butyricum. On the other hand, Smad2D/D
BMDCs produced two times higher concentrations of TGF-b
compared withWTBMDCs. Similar positive and negative effects
of Smad2 and Smad3 deficiency on TGF-b protein secretion was
confirmed in BMDCs stimulated with LPS and E. coli (Fig-
ure S4D). We next stimulated BMDCs with exogenous TGF-b
to show autoinduction of TGF-b. Much lower amounts of Tgfb1
mRNA were detected in Smad3/ BMDCs stimulated with
TGF-b compared with WT BMDCs, whereas higher induction
of Tgfb1mRNA in Smad2D/D BMDCs were observed (Figure 4B).
Similarly, Tgfb1 expression was much higher in LPDCs from
Smad2DDC/DDC mice than in those from WT mice, whereas
LPDCs from Smad3/ mice poorly responded to PGN and
TGF-b (Figure 4C).
Next we compared iTreg cell induction potential by BMDCs
in vitro. Smad3/ BMDCs primed with either PGN induced
lower fraction of iTreg cells than WT BMDCs by allogenic MLR,
whereas Smad2D/D BMDCs induced higher fraction of iTreg cells
(Figures 4D and 4E). This enhanced iTreg cell generation induced
by Smad2D/D DCs was dependent on endogenous TGF-b, as
shown by the fact that TGF-b-neutralizing Ab severely reduced
iTreg cell generation (Figure S4E). These data indicate that
Smad3 transmits the TGF-b receptor signal that is essential for
TGF-b autoinduction and iTreg cell generation, whereas
Smad2 negatively regulates these processes.
To confirm the respective positive and negative effects of
Smad3 and Smad2 for TGF-b autoinduction, we transduced
Smad2 and Smad3 cDNA into BMDCs by using retrovirus, and(C) Murine TGF-b1 promoter genomic sequence homology to that of human (Hu
Highly conserved regions were designated as CNS1 and CNS2. Position of the t
(D) Promoter-reporter assay. The indicated murine Tgfb1 promoter reporter con
reporter plasmid, and then cells were stimulated with or without 100 ng/ml PGN
(RLA/b-gal). The conserved AP-1 binding site within CNS2 is shown as a circle (
(E) BMDCs were stimulated by 100 ng/ml LPS or PGN for 6 hr, and then the ChIP a
acetylated histone H3 (AcH3) Abs. Data were pooled from two independent exp
(F) TGF-b protein concentrations secreted from WT or c-FosD/D BMDCs stimulat
(G) ChIP assay was performed with AcH3 Ab for the AP-1 binding region (1508
(H) Tgfb1 and Fos mRNA contents in LPDCs isolated from WT or FosDDC/DDC mi
Hprt (n = 3).
(I) The percentage of Foxp3+ within the CD4+ cells (left) and the percentage of Nr
mice (n = 3).
All data represent the mean ± SEM (n = 3); *p < 0.05, **p < 0.01. Data were poolBMDCs were stimulated with PGN or TGF-b. Forced expression
of Smad3 resulted in higher production of TGF-b in response to
PGN or TGF-b compared with control BMDCs, whereas Smad2
expression suppressed TGF-b induction (Figure 4F). Forced
expression of Smad3 resulted in spontaneous TGF-b expression
in BMDCs without any stimulation. Thus, we concluded that
Smad3 transmits positive signals, whereas Smad2 transmits
negative signals for TGF-b production in BMDCs.
Smad3 Induces Active Histone Modifications of the
TGF-b Promoter
Next, we investigated the mechanisms for opposite regulation of
TGF-b expression by Smad2 and Smad3. Smad3 regulates
transcription of target genes through direct binding to the
Smad-binding element (SBE) (Massague´ et al., 2005). TGF-b
promoter reporter assay via HEK293T cells revealed that
Smad3 directly enhanced Tgfb1 promoter activity in vitro
whereas Smad2 did not. Deletion mutant experiments sug-
gested that a Smad3-responsive region was included within
585 bp upstream region of the promoter (Figure 5A). This region
contains the CNS1 (265 to1), which is adjacent to exon 1 and
highly conserved among species (Figure 3C), and there are a
number of SBE core sequences (50-AGAC-30) (Figure 5A). We
then searched the actual Smad binding sites in the promoter in
BDMCs stimulated with TGF-b via a ChIP assay. Both Smad2
and Smad3 bound to the SBE-rich CNS1 region around the tran-
scription initiation site (Figure 5B); however, the peak position of
the Smad3 binding was slightly different from that of Smad2.
Notably, Smad3 binding was strongly enhanced in Smad2D/D
BMDCs, whereas Smad2 binding was promoted in Smad3/
BMDCs after TGF-b treatment (Figure 5C), suggesting that the
recruitment of Smad3 to the CNS1 region resulted in activation
of Tgfb1 transcription, whereas that of Smad2 inhibited tran-
scription. Smad4 was mainly recruited the Smad2 binding
sites (probably due to a high Smad2 protein expression in
DCs) (Figure S5A). However, Re-ChIP assay indicated that the
Smad2-Smad4 complex was also recruited to the same
Smad3-Smad4 binding site.
We next investigated histone modifications that affect tran-
scription (Figure 5D). After TGF-b stimulation, 196 to 113 of
the CNS1 showed the strongest Smad3 binding and tran-
scriptionally active histone modifications (AcH3, AcH4, and
H3K4me3) in WT BMDCs. AcH3 modification was observed in
this region in BMDCs after long stimulation with PGN (Fig-
ure S5B). This region exhibited more transcriptionally active) and bovine (Bv) estimated by ECR Browser (http://ecrbrowser.dcode.org/).
hird exon of B9d2 is shown. Blue color means protein-coding region.
structs were transfected into HEK293-TLR2 cells together with control b-gal
for 24 hr and luciferase activity was measured and normalized to b-gal activity
1403 to 1397).
ssay for the corresponding regions was performed with anti-c-Fos, c-Jun, and
eriments.
ed with LPS, PGN, or C. butyricum for 24 hr.
to 1291) using PGN-stimulated WT or Fos/ BMDCs.
ce administrated with CB for 14 days. Each mRNA amount was normalized to
p1 cells within the Foxp3+CD4+ cells (right) in the colonic LP of the indicated
ed from two independent experiments. See also Figure S3.
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Figure 4. Opposing Roles of Smad2 and Smad3 in Autoinduction of TGF-b in DCs
(A) TGF-b secretion fromWT, Smad2D/D, and Smad3/ BMDCs. BMDCs (13 106) were stimulated with 100 ng/ml PGN or 13 107 heat-killed C. butyricum (CB)
for 24 hr and total TGF-b concentrations were determined by the SEAP assay.
(B) Tgfb1 mRNA were normalized to Hprt in WT, Smad2D/D, and Smad3/ BMDCs stimulated with PGN, C. butyricum, or 5 ng/ml TGF-b for 3 hr.
(C) LPDCs isolated from WT, Smad2D/D, and Smad3/ mice were stimulated with 100 ng/ml PGN or 5 ng/ml TGF-b for 6 hr. Relative Tgfb1 mRNA amounts
normalized to Hprt are shown (n = 3).
(legend continued on next page)
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histone modifications (AcH3, AcH4, and H3K4me3) and fewer
repressive modifications (H3K9me3 and H3K27me3) in
Smad2D/D BMDCs compared with WT BMDCs (Figure 5D). In
contrast, Smad3/ BMDCs showed lower active histone mod-
ifications than did WT BMDCs (Figure 5D). These data suggest
that Smad3 induces active histone modifications, whereas
Smad2 induces repressive ones.
To confirm this, we examined recruitment of histone acetyl-
transferase (HAT) p300 to the Tgfb1 promoter (Figure 5E).
Consistent with histone acetylation data (Figure 5D), many
more p300 molecules were recruited to the CNS1 region in
Smad2D/D BMDCs than in WT BMDCs, whereas p300 recruit-
ment was severely reduced in Smad3/ BMDCs (Figure 5E). It
has been reported that Smad3-p300 interaction is required for
Smad3-dependent transcription (Feng et al., 1998; Janknecht
et al., 1998). Consistent with these reports, p300 was bound
only to Smad3 (not to Smad2 and Smad4) in HEK293T cells (Fig-
ure S5C). Thus, Smad3 but not Smad2 recruits p300 to the CNS1
region, thereby promoting active histone modification and lead-
ing to Tgfb1 transcription. On the other hand, a repressive his-
tone modification, H3K9me3, was enhanced in Smad3/
BMDCs (Figure 5D), suggesting that Smad2 might recruit H3K9
methyltransferases to the Tgfb1 promoter.
Smad2-Deficient DCs Are Tolerogenic
Because Smad2D/D BMDCs expressed higher TGF-b and
induced more iTreg cells in vitro compared with WT BMDCs,
we investigated the effect of Smad2 deficiency in DCs in vivo.
Colonic LP CD4+ T cells contained higher fraction of Foxp3+
Treg cells in Smad2DDC/DDC mice compared with WT mice un-
der our specific-pathogen-free (SPF) conditions (Figures 6A
and 6B). No significant difference in iTreg cells was observed
in mLN between WT and Smad2DDC/DDC mice. The develop-
ment of colonic CD11b+CD103+, CD11bCD103+, and
CD11b+CD103 DCs was normal in Smad2DDC/DDC mice (Fig-
ures S6A and S6B); however, Tgfb1 mRNA content in LPDCs
from Smad2DDC/DDC mice was higher than those from WT
mice (Figure 6C).
Administration of antibiotics resulted in reduced colonic Treg
cell fraction in Smad2DDC/DDC mice compared to that in WT
mice (Figures 6A and 6B), indicating that the enhanced Treg
cell development in Smad2DDC/DDC mice was dependent on in-
testinal bacterial flora. Consistent with the increase of Treg cells
in the colon of Smad2DDC/DDC mice, Smad2DDC/DDC mice were
resistant to DSS-induced colitis (Figures 6D, S6C, and S6D).
Expression of IL-10 and TGF-b1 increased in LPDCs of DSS-
treated Smad2DDC/DDC mice compared with WT mice, whereas
expression of inflammatory cytokines including TNF-a, IL-6,
and IL-12p40 was decreased (Figure 6E). In addition, the
IFN-g+ fraction in CD4+ T cells was lower, whereas the Foxp3+
fraction was higher in the LP of Smad2DDC/DDC mice than in WT
mice after DSS treatment (Figure 6F).(D and E) iTreg cell induction by Smad2D/D or Smad3/ BMDCs. BALB/c naive
which were primed with PGN orC. butyricum for 24 hr. Foxp3+ and CD4+ T cell we
T cells are shown quantitatively in (E). Data represent the mean ± SEM (n = 5). *p
(F) BMDCs infected with the retrovirus carrying Smad2 or Smad3 were stimulated
normalized to Hprt. Data represent the mean ± SEM (n = 3).
*p < 0.05, **p < 0.01. Data are representative of three independent experiments.Next, we investigated whether Smad2-deficient BMDCs were
tolerogenic in vivo. PGN-treated Smad2D/D BMDCs produced
high amount of TGF-b (Figure 4A); however, they expressed
lower CD86, class II major histocompatibility complex (MHC)
glycoproteins, and inflammatory cytokines than WT BMDCs
(Figures 7A–7C), which are characteristic in tolerogenic DCs.
We adoptively transferred Smad2D/D orWTBMDCs intoRag2/
mice together with naive T cells. Transfer of naive T cells into
Rag2/ mice resulted in the development of fatal colitis. Co-
transfer of WT BMDCs exacerbated colitis, whereas Smad2D/D
BMDCs ameliorated colitis and reduced mortality (Figures 7D
and 7E). WT BMDC transfer slightly increased LP IFN-g+CD4+
T cells, whereas Smad2D/D BMDCs decreased IFN-g+ cells (Fig-
ure S7A). Smad2D/D BMDC transfer, highly increased Foxp3+
cells in the colon, which was restored by the treatment with
anti-TGF-b Ab (Figure 7F). A similar protective effect of
Smad2D/DBMDCs was observed in a DSS-induced colitis model
(Figures S7B and S7C). In this model, transfer of Smad3/
BMDCs rather deteriorated colitis.
DISCUSSION
TGF-b is a pleiotropic cytokine that plays an essential role in
immune homeostasis. One of the important functions of TGF-b
for immune regulation is the induction of Foxp3+ Treg cells,
which are called iTreg or peripheral Treg (pTreg) cells. Various
types of cells have been shown to secrete TGF-b, but the major
producer for iTreg cell generation in the gut remains to be eluci-
dated. LPDCs are the strongest candidate for iTreg cell genera-
tion in the colon; a number of reports attributed the major contri-
bution of local iTreg cell accumulation to LPDCs (Benson et al.,
2007; Coombes et al., 2007; Ruane and Lavelle, 2011; Sun
et al., 2007). Indeed, we found that LPDCs produced much
higher amounts of TGF-b in response to C. butyricum than
epithelial cells.
LPDC populations have been shown to contain two distinct
subsets: CD103+CX3CR1
 LPDCs developed from pre-cDCs
through a Flt3L growth-factor-mediated pathway and CD11b+
CD14+CX3CR1
+ LPDCs derived from Ly6Chi monocytes under
the control of granulocyte monocyte-colony stimulating factor
(GM-CSF) (Varol et al., 2009). We have shown here that the
CD103+CX3CR1
 LPDC population most highly produced
TGF-b in response to C. butyricum, which is consistent with
the report showing that CD103+ LPDCs suppress DSS-induced
colitis (Varol et al., 2009). Although BMDCs were generated by
GM-CSF, Smad2/ BMDCs had tolerogenic potential with a
high TGF-b expression. Further biochemical characterization of
the TGF-b signaling might uncover a new mechanism of tolero-
genic potential of CD103+ LPDCs.
An increasing amount of evidence demonstrates a tight link
between intestinal microbiota and local and systemic immune
regulation including modification of helper T cell development.CD4+ T cells were cocultured for 3 days with the indicated genotype BMDCs,
re analyzed by flow cytometry (D). The percentage of Foxp3+ cells among CD4+
< 0.05, **p < 0.01.
by 100 ng/ml LPS, 100 ng/ml PGN, or 5 ng/ml TGF-b for 3 hr. Tgfb1mRNAwas
See also Figure S4.
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Figure 5. Smad2 and Smad3 Induce Distinctive Histone Modifications on the Tgfb1 Promoter
(A) Smad-responsive region on the Tgfb1 promoter. The indicated reporter plasmids were transfected into HEK293T cells together with Smad2 or Smad3
expression vectors. Luciferase activity in the cell lysates was measured and normalized to b-gal activity. Positions of the core SBE are shown as circles.
(B) WTBMDCswere stimulated with 5 ng/ml TGF-b for 6 hr, and then ChIP assay for indicated regions was performedwith anti-Smad2 and anti-Smad3 Abs. n = 3
for each point.
(C) WT, Smad2D/D, and Smad3/ BMDCs were stimulated with TGF-b, and the ChIP assay for 196 to 113 region was performed with anti-Smad2 and
Smad3 Abs.
(D) Histone modifications in WT, Smad2D/D, and Smad3/ BMDCs stimulated with TGF-b. The ChIP assay for the 196 to 113 region was performed with the
indicated Abs.
(E) The ChIP assay with anti-p300 Ab for the indicated regions in WT, Smad2D/D, and Smad3/ BMDCs stimulated with TGF-b.
All data present the mean ± SEM (n = 3). *p < 0.05, **p < 0.01. Data were pooled from three independent experiments. See also Figure S5.Treg cells are present at higher populations in the gut LP than in
the other organs, and 1/2 to 2/3 of gut LP Treg cells are iTreg
cells, which are probably dependent on TGF-b (Josefowicz
et al., 2012). We showed here that intake of the gram-positive
organism C. butyricum enhanced colonic LP iTreg cell develop-74 Immunity 43, 65–79, July 21, 2015 ª2015 Elsevier Inc.ment under normal feeding conditions, leading to resistance to
DSS-induced colitis. Similarly, it has been reported that adminis-
tration of probiotic strains of bifidobacteria and lactobacilli
suppress colitis by inducing Treg cells in mice (Di Giacinto
et al., 2005; Karimi et al., 2009; Lyons et al., 2010), and human
Figure 6. Smad2DDC/DDC Mice Show Higher Fractions of Intestinal iTreg Cells and Are More Resistant to DSS-Induced Colitis than WT Mice
(A and B) Treg cell population in the LP or mLN of Smad2DDC/DDC mice. Mice were maintained under SPF conditions or treated with antibiotics (Abx) for 14 days.
Mononuclear cells from colonic LP or mLN were stained with anti-CD4, anti-CD25, and anti-Foxp3 Abs and analyzed with a flow cytometer. Representative flow
(legend continued on next page)
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commensal Bacteroides fragilis facilitates Treg cell differentia-
tion and IL-10 induction, thereby suppressing experimental
autoimmune encephalomyelitis (Ochoa-Repa´raz et al., 2010;
Round and Mazmanian, 2010). Therefore, both IL-10 and Treg
cell induction are involved in the effect of probiotic bacteria on
immune regulation.
Induction of iTreg cells by C. butyricum is consistent with
recent reports showing a preferential induction of Treg cells by
murine and human Clostridium species (Atarashi et al., 2011,
2013). However, it is still unclear why particular Clostridium spe-
cies specifically enhance iTreg cell generation. We showed that
TLR-mediated ERK-AP-1 activation was an early event to
activate theTgfb1 promoter and confirmed that TLR2 ligands
activated AP-1more strongly than TLR4 ligands. Therefore, pref-
erential activation of TLR2 by Clostridia could be one mecha-
nism. However, not all gram-positive bacteria promote iTreg
cell development in mice. One possibility is that the different
bacterial species produce different metabolites, because they
produce different short chain fatty acids as described recently
(Arpaia et al., 2013; Furusawa et al., 2013). Particular bacterial
components might be involved, for example, a symbiosis factor
(PSA, polysaccharide A) of B. fragilis promotes iTreg cell gener-
ation through TLR2 expression on Treg cells (Round et al., 2011)
or DCs (Shen et al., 2012). Another possible mechanism is that
DCs express distinctive cytokine patterns in response to
different bacterial species.
Our study revealed a sequential mechanism of TGF-b1 pro-
duction in DCs though AP-1 and Smad3. The role of AP-1 on
Tgfb1 expression has been reported in tumor cells (Birchenall-
Roberts et al., 1990) and hepatocytes (Presser et al., 2013). How-
ever, AP-1 sites proposed in these studies located within the
proximal region of the Tgfb1 promoter and were not conserved
between human and mouse. Neither study examined the distal
region of the promoter including the AP-1 site we identified
(1403 to 1397). We also demonstrated autocrine activation
of the Tgfb1 promoter by Smad3. Previously, TGF-b-mediated
Tgfb1 promoter activation was reported in human lung adeno-
carcinoma cells, although the contribution of Smads was not
considered (Kim et al., 1990). One paper suggested the involve-
ment of Smad3 (Sato et al., 2003), but the Smad-binding region
has not been identified. In addition, signals other than AP-1
might also play a role in the Tgfb1 promoter activation. Indeed,
we observed that a p38 inhibitor strongly suppressed Tgfb1
expression in BMDCs, although we have not identified the tran-
scription factor downstream of p38. We also showed that STAT3
is involved in the activation of the Tgfb1 promoter in T cells (Kin-
jyo et al., 2006). It is possible that cell-type-specific transcription
factors and signals might regulate TGF-b1 gene expression.
Another novel finding of our study is the negative role of
Smad2 in TGF-b production in DCs. In T cells, we have shown
that most of the TGF-b-induced or -repressed genes are redun-cytometry profiles of CD25+ and Foxp3+ cells in the CD4+ T cell fraction are shown
T cells in (B) (n = 5).
(C) Tgfb1 mRNA amounts were measured with qRT-PCR in LPDCs isolated from
(D–F) DSS-induced colitis in WT and Smad2DDC/DDC mice. Body weight change o
amounts of LPDCs isolated from DSS-treated WT or Smad2DDC/DDC mice were
isolated from LP or mLN of WT and Smad2DDC/DDC mice on day 8. Representativ
*p < 0.05, **p < 0.01. See also Figure S6.
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For example, Smad2 and Smad3 are redundantly essential for
Foxp3 induction (Takimoto et al., 2010), IL-9 expression (Tamiya
et al., 2013), and IL-2 suppression (Wakabayashi et al., 2011) by
TGF-b in T cells. Similarly, both Smad2 and Smad3 are important
for the suppression of Nos2 expression in macrophages
(Sugiyama et al., 2012). Thus, Tgfb1 is a rare genewhich is oppo-
sitely regulated by Smad2 and Smad3. We propose that recruit-
ment of p300 by Smad3 to the Tgfb1 promoter is important
because Smad2 does not bind to p300. Therefore, simple
competition between active Smad3-Smad4 complex and silent
Smad2-Smad4 complex to the Smad binding sites in the pro-
moter might explain the opposite functions. Smad2 might also
recruit transcription-repressive H3K9 methyltransferases to the
Tgfb1 promoter as observed in the Il2 promoter (Wakabayashi
et al., 2011).
We showed a strong tolerogenic potential of Smad2D/D DCs.
TGF-b signals in DCs must play essential roles in generating tol-
erogenic DCs. In addition to TGF-b expression, tolerogenic DCs
should express low amount of co-stimulators, class II MHCs,
and inflammatory cytokines such as IL-12. Smad2 deficiency
confers all the phenotypes necessary for Treg-cell-inducing tol-
erogenic DCs. We previously reported that, like Smad2D/D DCs,
Socs3-deficient DCs showed similar tolerogenic phenotypes,
namely, high TGF-b production and strong iTreg cell induction
potential (Matsumura et al., 2007). In this case, higher STAT3
activation could be involved in the tolerogenic features of
Socs3-deficient DCs, suggesting a cooperation of STAT3 and
Smad3 for tolerogenicity in DCs. Specific inhibition of Smad2
or Socs3 expression by siRNA or gene editing methods might
facilitate generation of tolerogenic DCs.EXPERIMENTAL PROCEDURES
Mice
All mice used in this study were a C57BL/6 background. Tlr2/, Tlr4/, and
Tlr2/Ttlr4/ mice were provided by Dr. S. Akira (Osaka University) and Dr.
K. Miyake (Tokyo University). Mice with DC-specific Smad2 deletion (Itgax-
cre-Smad2flox/flox) were generated by crossing Itgax-cre transgenic mice
(Jackson Laboratory) andSmad2flox/flox mice (Ichiyama et al., 2011).Smad3/
mice were provided by Dr. S. Saika (Wakayama Medical School). DC-specific
Fos/ (Itgax-cre-Fosflox/flox) mice will be described elsewhere. All mice were
housed in clean animal rooms under SPF conditions. All experiments with
these mice were approved by and performed according to the guidelines of
the animal ethics committee of Keio University, Tokyo, Japan. See Supple-
mental Experimental Procedures for colitis models, anti-TGF-b Ab treatment,
and colonic cell preparation and flow cytometry analysis.
Bacteria Preparation
Clostridium butyricum MIYAIRI 588 (C. butyricum) used in this study was ob-
tained from Miyarisan Pharmaceutical, as described (Hayashi et al., 2013). A
gram-negative nonpathogenic strain of E. coli (25922; American Type Culture
Collection) was cultured in Luria-Bertani medium. Bacteria were harvested andin (A). Quantitative analysis of the percentage of Foxp3+ Treg cells amongCD4+
WT or Smad2DDC/DDC mice under normal diet conditions.
f mice treated with and without 1.0% DSS for indicated periods (D). Cytokine
measured with qRT-PCR (n = 5). (E) IFN-g and Foxp3 staining in CD4+ T cells
e data of three independent experiments are shown (F).
Figure 7. Tolerogenic Potential of Smad2-Deficient BMDCs
(A–C) BMDCs from WT or Smad2DDC/DDC mice were stimulated with 100 ng/ml PGN for 24 hr. BMDCs were stained with anti-CD86
and MHC class II (I-Ab) Abs and analyzed with flow cytometry (A) and quantified in (B). Cytokine concentrations in the culture of BMDCs from WT or
Smad2DDC/DDC mice were determined with ELISA (C). Data are presented as the mean ± SEMs (n = 5). Data are representative of three independent
experiments.
(D–F) Effect of WT and Smad2D/D BMDCs on colitis of Rag2/ mice adoptively transferred with CD4+CD62Lhi naive T cells. PGN-primed BMDCs (13 106 cells)
were transferred intoRag2/mice on day2 and day5 before transferring naive T cells. Changes in body weight (D) and survival (E) weremeasured daily (n = 8
(legend continued on next page)
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washed twice with ice-cold PBS. Mice were fed with a diet containing 1 3 109
colony-forming units/g C. butyricum spore for 2 weeks as described (Hayashi
et al., 2013). For heat-killed bacteria preparations, bacterial suspensions were
boiled for 30min, washed, re-suspended in PBS, and stored at80C until use.
Antibodies and Reagents
See Supplemental Experimental Procedures for antibodies, reagents, and
biochemical assays.
Measurement of TGF-b
The TGF-b concentration was determined by bioassay with MFB-F11 cells as
described (Matsumura et al., 2007). See Supplemental Experimental Proce-
dures for Secreted Alkaline Phosphatase (SEAP) assay.
BMDC Preparation and MLR
BMDCswere prepared from bonemarrow suspensions from femurs and tibias
inmice as described (Matsumura et al., 2007). See Supplemental Experimental
Procedures for isolation of native T cells and MLR.
mRNA Preparation and Quantitative RT-PCR
Total RNA was extracted with RNAiso Plus (TAKARA BIO) and subjected to
reverse transcription with a High Capacity cDNA Synthesis Kit (Applied
Biosystems). PCR analysis was performed with an iCycler iQ multicolor real-
time PCR detection system (Bio-Rad) and SsoFast EvaGreen Supermix (Bio-
Rad) with the indicated primer sets in Table S1. Relative expression levels
were normalized to Hprt.
Chromatin Immunoprecipitation Assay
AChIP assay for various transcription factors was performed as described pre-
viously (Tamiya et al., 2013). In brief, BMDCswere fixed with 1% formaldehyde
at room temperature for 60minand then suspended in anSDS lysis buffer. After
sonication by the S220 Forcused-ultrasonicator (Covaris), samples were incu-
bated with 2 mg antibodies or control IgG for 4 hr at 4C. After the addition
of Dynabeads protein G (Life Technologies), the immunoprecipitates were
sequentially washed once each with a low-salt buffer, a high-salt buffer, a
LiCl buffer, and twice with a TE buffer. The DNA-protein complex was eluted
by heating at 65C overnight. Proteins were then digested with proteinase K.
DNA was recovered with the QIAquick PCR Purification Kit (QIAGEN) and
then subjected to real-time PCR analysis. The primer sets are described in
Table S2. See Supplemental Experimental Procedures for Re-ChIP assay.
Statistics
A paired, two-tailed Student’s t test was used. Values of p < 0.05 were consid-
ered significant. All error bars represent the SEM.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, two tables, and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.immuni.2015.06.010.
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